Cover Image

Integrating in vivo and ex vivo approaches for culprit drug identification in cutaneous adverse drug reactions from non‐beta lactam antibiotics

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Narumol Ratanasutiranont, Pungjai Mongkolpathumrat, Patcharapong Rujirawan, Pawinee Rerknimitr, Jettanong Klaewsongkram
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Experimental Dermatology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

In‐vivo and ex‐vivo tests for culprit drugs identification in severe cutaneous adverse drugs reactions
by: P. Sittiwattanawong, et al.
Published: (2024)

Combining dipyridamole and cilostazol with up‐dosing antihistamines improves outcomes in chronic spontaneous urticaria with high D‐dimer levels: A randomized controlled trial
by: Amornrat Prasertcharoensuk, et al.
Published: (2024)

Nail Fold Microbiome Alterations in Patients Treated With Epidermal Growth Factor Receptor Inhibitors
by: N. Somboonna, et al.
Published: (2026)

A Randomized Controlled Study of the Efficacy of a Topical Antifungal, Antimicrobial, Anti‐Inflammatory, and Antiseborrheic Cream in Treating Mild to Moderate Facial Seborrheic Dermatitis
by: Kridipop Charoenchaipiyakul, et al.
Published: (2025)

Differential immune complex deposition in mild and severe drug‐induced cutaneous reactions
by: Hideo Hashizume, et al.
Published: (2024)

Severe adverse drug reactions induced by lamotrigine: Are prescription guidelines being followed?
by: Alice Thorn, et al.
Published: (2025)

Implications of drug resistance in leprosy: disease course, reactions and the use of novel drugs
by: Kabir Sardana, et al.
Published: (2024)

Incidence Trends and Severe in‐Hospital Outcomes of Pemphigus Vulgaris: A Nationwide Cohort Study
by: Rachot Wongjirattikarn, et al.
Published: (2026)

Effect of Epstein–Barr virus on macrophage M2 / M1 migration and EphA2 expression in adverse drug reactions
by: Ran An, et al.
Published: (2024)

Presurgical delimitation with tape skin markers and ex vivo ultrasound study of in transit melanoma metastases
by: Ismael Valladares Millán, et al.
Published: (2024)

Solitary cutaneous focal mucinosis: In‐vivo line‐field confocal optical coherence tomography (LC‐OCT) features correlate to histopathology
by: Gerardo Palmisano, et al.
Published: (2024)

Detection of basal cell carcinoma by machine learning‐assisted ex vivo confocal laser scanning microscopy
by: Pinar Avci, et al.
Published: (2024)

Granzyme B inhibition reduces autoantibody‐induced dermal–epidermal separation in an ex vivo model of epidermolysis bullosa acquisita
by: Shirin Emtenani, et al.
Published: (2024)

Characteristics of suitable cases for treatment with nemolizumab based on clinical findings and cutaneous adverse events
by: Akiko Sugiyama, et al.
Published: (2025)

Pediatric drug reaction with eosinophilia and systemic symptoms: A 12‐year retrospective study in a tertiary center
by: Susheera Chatproedprai, et al.
Published: (2024)

Treatment‐refractory granulomatous reaction to microneedling with transepidermal drug delivery of vitamin C, niacinamide, and botanical extracts
by: Daniel P. Friedmann, et al.
Published: (2024)

Causal effects of lipid‐lowering drugs on inflammatory skin diseases: Evidence from drug target Mendelian randomisation
by: Chenyang Zang, et al.
Published: (2024)

Delayed and immediate cutaneous adverse events during pembrolizumab combination chemotherapy against cervical cancer: Case series
by: Takeya Adachi, et al.
Published: (2024)

Guidelines for the management of drug‐induced hypersensitivity syndrome 2023
by: Yoshiko Mizukawa, et al.
Published: (2025)

Application of dermoscopy and reflectance confocal microscopy in vivo in the evaluation of nevi in children
by: Anna Pogorzelska‐Antkowiak, et al.
Published: (2024)

Immune cutaneous reactions in orf and in pseudocowpox viruses: clinicopathologic correlations and management to avoid misdiagnosis
by: Giovanni Paolino, et al.
Published: (2024)

Prevention and management of cutaneous immune‐related adverse events: EADV Task Force statement
by: Davide Fattore, et al.
Published: (2025)

Characterizing drug‐induced epidermal necrolysis in a pediatric cohort
by: Ariel B. Brown, et al.
Published: (2024)

Psoriasiform drug eruption: A case series with a review of the literature
by: Miho Mori, et al.
Published: (2024)

Effectiveness of trabectedin for radiation‐induced angiosarcoma of the breast refractory to several anticancer drugs
by: Erina Matsuzaki, et al.
Published: (2024)

Pharmacology of drugs used in autoimmune dermatopathies in cats and dogs: A narrative review
by: Heng L. Tham, et al.
Published: (2024)

Ex vivo therapeutic screening of metastatic cSCC: A review of methodological considerations for clinical implementation
by: Jessica Conley, et al.
Published: (2024)

Loss of CELF2 promotes skin tumorigenesis and increases drug resistance
by: Bindeshwar Sah, et al.
Published: (2024)

Rosacea treatment with mussel adhesive protein delivered via microneedling: In vivo and clinical studies
by: Yinli Luo, et al.
Published: (2024)

Petrolatum versus saline vehicle for drug testing
by: Haudrey Assier, et al.
Published: (2025)

Treating tislelizumab‐induced ulcerative lichenoid drug eruption with baricitinib in a patient with lung cancer
by: Jiaqi Lv, et al.
Published: (2025)

Anti‐IL17 Secukinumab in hidradenitis suppurativa: A long‐term drug survival analysis
by: Gabriele Roccuzzo, et al.
Published: (2024)

A bibliometric analysis of alternative drug therapy options in the treatment of androgenetic alopecia
by: Aditya K. Gupta, et al.
Published: (2024)

A facial lentiginous nevus with atypical clinical features in a child: The importance of in vivo reflectance confocal microscopic findings
by: Nilay Duman, et al.
Published: (2024)

Implications for cumulative and prolonged clinical improvement induced by cross‐linked hyaluronic acid: An in vivo biochemical/microscopic study in humans
by: Frank Wang, et al.
Published: (2024)

Development of treatment strategies by comparing the minimum inhibitory concentrations and minimum fungicidal concentrations of azole drugs in dermatophytes
by: Junichiro Hiruma, et al.
Published: (2024)

Doxycycline‐induced fixed drug eruption: The new epidemic?
by: Alice Brehon, et al.
Published: (2024)

Novel drugs for the management of recalcitrant erythema nodosum leprosum
by: Mayra Ianhez, et al.
Published: (2025)

An update on clinical trials for cutaneous lupus erythematosus
by: Lillian Xie, et al.
Published: (2024)

Elastin and collagen fibres in cutaneous wound healing
by: Leire Gardeazabal, et al.
Published: (2024)